Bicarbonate in cystic fibrosis
- PMID: 28732801
- DOI: 10.1016/j.jcf.2017.06.005
Bicarbonate in cystic fibrosis
Abstract
Background: Cystic fibrosis (CF, mucoviscidosis) is caused by mutations in the gene encoding CF transmembrane conductance regulator (CFTR), which is a chloride and bicarbonate channel necessary for fluid secretion and extracellular alkalization. For a long time, research concentrated on abnormal Cl- and Na+ transport, but neglected bicarbonate as a crucial factor in CF.
Methods: The present short review reports early findings as well as recent insights into the role of CFTR for bicarbonate transport and its defects in CF.
Results: The available data indicate impaired bicarbonate transport not only in pancreas, intestine, airways, and reproductive organs, but also in salivary glands, sweat duct and renal tubular epithelial cells. Defective bicarbonate transport is closely related to the impaired mucus properties and mucus blocking in secretory organs of CF patients, causing the life threatening lung disease.
Conclusions: Apart from the devastating lung disease, abrogated bicarbonate transport also leads to many other organ dysfunctions, which are outlined in the present review.
Keywords: Bicarbonate; CFTR; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Mucoviscidosis; Mucus.
Copyright © 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Similar articles
-
HCO3- transport in relation to mucus secretion from submucosal glands.JOP. 2001 Jul;2(4 Suppl):280-4. JOP. 2001. PMID: 11875272 Review.
-
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion.J Clin Invest. 2009 Sep;119(9):2613-22. doi: 10.1172/JCI38662. Epub 2009 Aug 24. J Clin Invest. 2009. PMID: 19726884 Free PMC article.
-
Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.Lancet. 2008 Aug 2;372(9636):415-7. doi: 10.1016/S0140-6736(08)61162-9. Lancet. 2008. PMID: 18675692 Review.
-
Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.Am J Respir Med. 2003;2(4):299-309. doi: 10.1007/BF03256658. Am J Respir Med. 2003. PMID: 14719996 Review.
-
Pendrin Mediates Bicarbonate Secretion and Enhances Cystic Fibrosis Transmembrane Conductance Regulator Function in Airway Surface Epithelia.Am J Respir Cell Mol Biol. 2019 Jun;60(6):705-716. doi: 10.1165/rcmb.2018-0158OC. Am J Respir Cell Mol Biol. 2019. PMID: 30742493
Cited by
-
TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis.Int J Mol Sci. 2024 Sep 30;25(19):10551. doi: 10.3390/ijms251910551. Int J Mol Sci. 2024. PMID: 39408877 Free PMC article. Review.
-
Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice.Am J Physiol Lung Cell Mol Physiol. 2020 Mar 1;318(3):L518-L524. doi: 10.1152/ajplung.00287.2019. Epub 2020 Jan 29. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 31994896 Free PMC article.
-
Luminal Gastrointestinal Manifestations of Cystic Fibrosis.Curr Gastroenterol Rep. 2021 Mar 23;23(3):4. doi: 10.1007/s11894-021-00806-5. Curr Gastroenterol Rep. 2021. PMID: 33758994 Review.
-
CFTR Modulators: Does One Dose Fit All?J Pers Med. 2021 May 24;11(6):458. doi: 10.3390/jpm11060458. J Pers Med. 2021. PMID: 34073663 Free PMC article. Review.
-
SLC26A9 in airways and intestine: secretion or absorption?Channels (Austin). 2023 Dec;17(1):2186434. doi: 10.1080/19336950.2023.2186434. Channels (Austin). 2023. PMID: 36866602 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical